Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
AssigneesUniversity of Iowa Research Foundation, University of Kansas
InventorsZiying Yan, John F. Engelhardt, Jianming Qiu
Life of this patent
Estimating the term…
Abstract
A method of preparing a chimeric virus comprising bocavirus capsid protein (VP) and a recombinant adeno-associated (AAV) viral genome, and isolated mutant bocavirus genomes, are provided.
Claims24
A method of preparing a chimeric virus comprising bocavirus capsid protein (VP) and a recombinant adeno-associated (AAV) viral genome, comprising:
- a) providing a mutant bocavirus genome that when introduced to cells;
- i) does not express one or more of bocavirus NS1, NS2, NS3 or NS4;
- ii) expresses bocavirus VP1, VP2 and VP3;
- and
- iii) expresses bocavirus NP1;
- b) introducing the mutant bocavirus genome and a rAAV vector to cells which do not express one or more of bocavirus NS1, NS2, NS3 or NS4, thereby producing bocavirus VP, bocavirus NP1 and a rAAV genome;
- and
- c) collecting chimeric rAAV/bocavirus.
7-8. (canceled)
A method of preparing a chimeric virus comprising bocavirus capsid protein and a recombinant adeno-associated (AAV) viral genome which method is optionally independent of bocavirus NP1, comprising:
- a) providing one or more vectors that express bocavirus VP1, VP2 and VP3 and express bocavirus NP1, but do not express one or more of bocavirus NS1, NS2, NS3 or NS4 or, if the method is independent of bocavirus NP1 providing a mutant bocavirus genome that when introduced to cells i) do not express any of, or expresses one or more of, bocavirus NS1, NS2, NS3 or NS4, and ii) expresses bocavirus VP1, VP2 and VP3, iii) do not express a functional bocavirus NP1, wherein the coding region for the one or more of the VP1, VP2 or VP3 in the mutant vector is codon optimized;
- b) expressing the one or more vectors in cells that do not express one or more of bocavirus NS1, NS2, NS3 or NS4 and that have a rAAV vector of if the method is independent of bocavirus NP1, introducing the mutant bocavirus genome and a rAAV vector into cells that do not express bocavirus NP1 in trans, thereby producing bocavirus nonstructural proteins NS1, NS2, NS3 or NS4 capsid proteins and a rAAV genome;
- and
- c) collecting chimeric rAAV/bocavirus virus.
10-11. (canceled)
A method of preparing a chimeric virus comprising bocavirus capsid protein and a recombinant adeno-associated (AAV) viral genome, which method is independent of bocavirus NP1, comprising:
- a) providing one or more vectors that when introduced to cells i) do not express any of, or express one or more of, bocavirus NS1, NS2, NS3 or NS4, ii) express bocavirus VP1, VP2 and VP3, iii) do not express a functional bocavirus NP1, wherein the coding region for the one or more bocavirus VP1, VP2 or VP3 is codon optimized;
- b) expressing the one or more vectors and a rAAV vector in cells that do not express NP1 in trans, thereby producing bocavirus nonstructural proteins NS1, NS2, NS3 or NS4 capsid protein and a rAAV genome;
- and
- c) collecting chimeric rAAV/bocavirus.
An isolated mutant bocavirus genome that when introduced to cells i) does not express one or more of bocavirus NS1, NS2, NS3 or NS4;
- ii) expresses bocavirus VP1, VP2 and VP3;
- and iii) expresses bocavirus NP1;
- or a) expresses one or more of bocavirus NS1, NS2, NS3 or NS4;
- b) expresses bocavirus VP1, VP2 and VP3;
- and c) does not express a functional bocavirus NP1;
- or A) does not express any of bocavirus NS1, NS2, NS3 or NS4;
- B) expresses bocavirus VP1, VP2 and VP3;
- and C) does not express a functional bocavirus NP1.
24-25. (canceled)
27-28. (canceled)
Dependencies are inferred from the claim text.